A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection
- PMID: 25239077
- DOI: 10.1016/j.jhep.2014.09.014
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection
Comment on
-
First case of drug rash eosinophilia and systemic symptoms due to boceprevir.J Hepatol. 2014 Apr;60(4):891-3. doi: 10.1016/j.jhep.2013.12.008. Epub 2013 Dec 12. J Hepatol. 2014. PMID: 24333861
Similar articles
-
First case of drug rash eosinophilia and systemic symptoms due to boceprevir.J Hepatol. 2014 Apr;60(4):891-3. doi: 10.1016/j.jhep.2013.12.008. Epub 2013 Dec 12. J Hepatol. 2014. PMID: 24333861
-
Telaprevir-induced DRESS.J Drugs Dermatol. 2014 Feb;13(2):199-200. J Drugs Dermatol. 2014. PMID: 24509972
-
Direct-acting antiviral-associated dermatitis during chronic hepatitis C virus treatment.Am J Clin Dermatol. 2013 Dec;14(6):497-502. doi: 10.1007/s40257-013-0035-7. Am J Clin Dermatol. 2013. PMID: 23775427
-
Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.Pan Afr Med J. 2014 May 2;18:9. doi: 10.11604/pamj.2014.18.9.3799. eCollection 2014. Pan Afr Med J. 2014. PMID: 25360193 Free PMC article. Review.
-
Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.Australas J Dermatol. 2014 Feb;55(1):15-23. doi: 10.1111/ajd.12085. Epub 2013 Jul 19. Australas J Dermatol. 2014. PMID: 23866082 Review.
Cited by
-
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis.Case Reports Immunol. 2023 Feb 2;2023:1006376. doi: 10.1155/2023/1006376. eCollection 2023. Case Reports Immunol. 2023. PMID: 36778654 Free PMC article.
-
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.Int J Mol Sci. 2017 Jun 9;18(6):1243. doi: 10.3390/ijms18061243. Int J Mol Sci. 2017. PMID: 28598363 Free PMC article. Review.
-
Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C.J Dermatol Case Rep. 2014 Dec 31;8(4):95-102. doi: 10.3315/jdcr.2014.1183. eCollection 2014 Dec 31. J Dermatol Case Rep. 2014. PMID: 25621089 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources